Walleye Capital Portfolio holdings
AUM
$10.8B
1-Year Return
8.39%
This Quarter Return
+7.36%
1 Year Return
+8.39%
3 Year Return
+34.69%
5 Year Return
+89.54%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$1.78B
(+20%)
Cap. Flow
-$379M
Cap. Flow
% of AUM
-3.51%
Top 10 Holdings %
Top 10 Hldgs %
23.09%
Holding
2,398
New
504
Increased
593
Reduced
637
Closed
458
Top Buys
| 1 |
Microsoft
MSFT
|
+$440M |
| 2 |
Palantir
PLTR
|
+$167M |
| 3 |
AT&T
T
|
+$67.9M |
| 4 |
AutoZone
AZO
|
+$65.8M |
| 5 |
Caterpillar
CAT
|
+$58.8M |
Top Sells
| 1 |
Apple
AAPL
|
+$136M |
| 2 |
NVIDIA
NVDA
|
+$114M |
| 3 |
Netflix
NFLX
|
+$89.2M |
| 4 |
Occidental Petroleum
OXY
|
+$66.5M |
| 5 |
Mercado Libre
MELI
|
+$63.5M |
Sector Composition
| 1 | Technology | 24.91% |
| 2 | Consumer Discretionary | 17.84% |
| 3 | Financials | 10.77% |
| 4 | Industrials | 10.07% |
| 5 | Healthcare | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Trip.com Group
TCOM
$47.3B
| $833K | ﹤0.01% |
14,211
-3,203
| -18% | -$188K |
|
827
Asana
ASAN
$3.18B
| $833K | ﹤0.01% |
61,706
-14,913
| -19% | -$201K |
|
828
New York Times
NYT
$9.34B
| $825K | ﹤0.01% |
+14,738
| New | +$825K |
|
829
Chord Energy
CHRD
$5.96B
| $825K | ﹤0.01% |
+8,515
| New | +$825K |
|
830
Freedom Holding
FRHC
$10.2B
| $819K | ﹤0.01% |
+5,607
| New | +$819K |
|
831
AGNC Investment
AGNC
$10.8B
| $818K | ﹤0.01% |
+89,023
| New | +$818K |
|
832
Alamos Gold
AGI
$13.8B
| $817K | ﹤0.01% |
30,777
+23,732
| +337% | +$630K |
|
833
Generac Holdings
GNRC
$10.8B
| $815K | ﹤0.01% |
5,694
+4,669
| +456% | +$669K |
|
834
Metallus
MTUS
$692M
| $809K | ﹤0.01% |
52,495
+27,701
| +112% | +$427K |
|
835
Consolidated Edison
ED
$34.9B
| $809K | ﹤0.01% |
+8,060
| New | +$809K |
|
836
Clover Health Investments
CLOV
$1.53B
| $807K | ﹤0.01% |
289,196
+286,280
| +9,818% | +$799K |
|
837
Groupon
GRPN
$918M
| $805K | ﹤0.01% |
24,080
-77,657
| -76% | -$2.6M |
|
838
Aon
AON
$78.4B
| $805K | ﹤0.01% |
2,256
-5,444
| -71% | -$1.94M |
|
839
dLocal
DLO
$4.15B
| $803K | ﹤0.01% |
70,822
+70,681
| +50,128% | +$802K |
|
|
MBX
840
MBX Biosciences, Inc. Common Stock
MBX
$359M
| $803K | ﹤0.01% |
70,333
+37,843
| +116% | +$432K |
|
841
Structure Therapeutics
GPCR
$1.21B
| $802K | ﹤0.01% |
+38,673
| New | +$802K |
|
842
Encompass Health
EHC
$12.5B
| $800K | ﹤0.01% |
6,522
+6,271
| +2,498% | +$769K |
|
843
IBM
IBM
$239B
| $794K | ﹤0.01% |
2,695
+620
| +30% | +$183K |
|
844
Warner Bros
WBD
$30.1B
| $793K | ﹤0.01% |
69,215
+6,931
| +11% | +$79.4K |
|
845
Aquestive Therapeutics
AQST
$595M
| $787K | ﹤0.01% |
237,904
+198,323
| +501% | +$656K |
|
846
Avanos Medical
AVNS
$557M
| $786K | ﹤0.01% |
64,213
-1,390
| -2% | -$17K |
|
|
ASA
847
ASA Gold and Precious Metals
ASA
$761M
| $785K | ﹤0.01% |
24,871
+341
| +1% | +$10.8K |
|
848
RxSight
RXST
$407M
| $785K | ﹤0.01% |
60,358
-137,497
| -69% | -$1.79M |
|
849
Graham Corp
GHM
$527M
| $783K | ﹤0.01% |
+15,813
| New | +$783K |
|
850
Akebia Therapeutics
AKBA
$790M
| $782K | ﹤0.01% |
+214,817
| New | +$782K |
|